| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | immunoglobulin complex | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGLV3-22 LIME1 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 1.08e-06 | 166 | 170 | 10 | GO:0019814 |
| Domain | - | LRRC8E CARMIL3 PRAMEF19 LRRIQ4 TSHR OMD LHCGR CIITA TLR2 TONSL LUM SNRPA1 | 1.90e-05 | 321 | 158 | 12 | 3.80.10.10 |
| Domain | L_dom-like | LRRC8E CARMIL3 PRAMEF19 LRRIQ4 TSHR OMD LHCGR CIITA TLR2 TONSL LUM SNRPA1 | 2.35e-05 | 328 | 158 | 12 | IPR032675 |
| Domain | Leu-rich_rpt | 1.06e-04 | 271 | 158 | 10 | IPR001611 | |
| Domain | MFS_dom | 1.45e-04 | 134 | 158 | 7 | IPR020846 | |
| Domain | Prepro-melanin_conc_hormone | 2.12e-04 | 3 | 158 | 2 | IPR005456 | |
| Domain | Pro-MCH | 2.12e-04 | 3 | 158 | 2 | PF05824 | |
| Domain | HEAT_REPEAT | 3.16e-04 | 70 | 158 | 5 | PS50077 | |
| Domain | KASH | 4.22e-04 | 4 | 158 | 2 | IPR012315 | |
| Domain | KASH | 4.22e-04 | 4 | 158 | 2 | PS51049 | |
| Domain | KASH | 4.22e-04 | 4 | 158 | 2 | SM01249 | |
| Domain | KASH | 4.22e-04 | 4 | 158 | 2 | PF10541 | |
| Pubmed | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 1.94e-12 | 18 | 172 | 7 | 20399194 | |
| Pubmed | 3.46e-10 | 9 | 172 | 5 | 6777049 | ||
| Pubmed | 4.90e-10 | 20 | 172 | 6 | 10427970 | ||
| Pubmed | 1.26e-09 | 11 | 172 | 5 | 6795447 | ||
| Pubmed | Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis. | 1.26e-09 | 11 | 172 | 5 | 279004 | |
| Pubmed | Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes. | 1.26e-09 | 11 | 172 | 5 | 6767723 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NCAPD3 CNTNAP1 RANBP6 LAMB2 TMTC2 SLC30A1 CEMIP2 ITFG1 EDEM3 MYOF THADA IGF2R TBC1D4 MOGS FHOD1 CLPTM1 PRSS21 LRP1 TXNDC16 UTP20 UBAC2 LUM BACE2 PLXNA1 NOTCH1 | 1.39e-09 | 1201 | 172 | 25 | 35696571 |
| Pubmed | 1.17e-08 | 16 | 172 | 5 | 17124007 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | CAD POLR1A LARS1 PIGQ MYOF IGF2R CLN3 CLPTM1 STARD3 UBAC2 ABCG2 BACE2 SNRPA1 | 8.99e-08 | 392 | 172 | 13 | 33144569 |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 33472039 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CAD DDX17 POLR1A MYO5B SYNE1 SF3A1 LARS1 LAMB2 TEX10 WDR3 TRAP1 PBRM1 IGF2R SACS SYNE2 UTP20 CCAR2 SNRPA1 IMP3 NEURL4 | 1.96e-07 | 1024 | 172 | 20 | 24711643 |
| Pubmed | 5.56e-07 | 14 | 172 | 4 | 19874786 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | LRRC8E NCAPD3 PCDHB5 TUSC3 CNTNAP1 LAMB2 TEX10 SLC30A1 CEMIP2 ITFG1 PREB WDR3 PBRM1 IGF2R TBC1D4 MOGS MORF4L1 FHOD1 CLPTM1 LRP1 UBAC2 | 5.94e-07 | 1203 | 172 | 21 | 29180619 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 8.17e-07 | 202 | 172 | 9 | 33005030 | |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 6086934 | ||
| Pubmed | CAD DDX17 TUSC3 CNTNAP1 TTC27 LAMB2 CEMIP2 ITFG1 EDEM3 TRAP1 IGF2R PRSS21 LRP1 PLXNA1 | 2.49e-06 | 613 | 172 | 14 | 22268729 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRRC8E LAMB2 UBL4A MED13L SLC35E2B FHIP1B DCTN1 HDAC7 FOCAD LIME1 MYOF THADA TNRC18 IGF2R KANSL1 CLN3 TAGLN PLXNA1 NOTCH1 | 2.65e-06 | 1105 | 172 | 19 | 35748872 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 DDX17 SYNE1 SF3A1 TRPS1 TTC27 DCTN1 PREB EDEM3 TRAP1 PBRM1 KANSL1 SUGT1 ARID2 CCAR2 ABCG2 SNRPA1 NEURL4 DDX28 | 4.99e-06 | 1155 | 172 | 19 | 20360068 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | MAG PPP1R21 KNTC1 CAD PRAMEF19 TTC27 TRAP1 IGF2R FHOD1 IFT122 ALDH1A3 NEURL4 DDX28 | 5.21e-06 | 564 | 172 | 13 | 21565611 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | POLR1A MYO5B SF3A1 HDAC7 PREB WDR3 MYOF SACS FHOD1 CCAR2 TAGLN | 5.48e-06 | 400 | 172 | 11 | 35013556 |
| Pubmed | KDM3A TTC28 SYNE1 CNTNAP1 TRPS1 LARS1 TTC27 MED13L SEC31B DCTN1 FOCAD PLEKHH1 WDR3 SACS SBNO1 MORF4L1 LRP1 IFT122 BACE2 AGAP2 | 6.29e-06 | 1285 | 172 | 20 | 35914814 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 NCAPD3 CAD DDX17 POLR1A SYNE1 SF3A1 LARS1 DCTN1 WDR3 TRAP1 THADA TRMT6 PBRM1 IGF2R MOGS SBNO1 UTP20 CCAR2 SNRPA1 PLXNA1 | 8.35e-06 | 1425 | 172 | 21 | 30948266 |
| Pubmed | HSCB NCAPD3 CAD DDX17 PREB TRAP1 IGF2R FHOD1 CLPTM1 LRP1 TXNDC16 UBAC2 TBR1 DDX28 | 8.94e-06 | 686 | 172 | 14 | 28380382 | |
| Pubmed | KNTC1 DDX17 PCDHGC4 MYO5B SYNE1 ATP10B SRBD1 TEX10 DCTN1 PGK2 TRAP1 TNRC18 MLIP SACS SBNO1 SYNE2 SCN9A CCAR2 IFT122 TOP1MT AGAP2 | 9.98e-06 | 1442 | 172 | 21 | 35575683 | |
| Pubmed | NCAPD3 CNTNAP1 TRPS1 LARS1 RANBP6 UBL4A PREB EDEM3 MOGS CCAR2 IFT122 | 1.90e-05 | 457 | 172 | 11 | 22190034 | |
| Pubmed | 1.90e-05 | 11 | 172 | 3 | 22826121 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 2293030 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11792814 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 34223928 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.43e-05 | 2 | 172 | 2 | 24931616 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25796442 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26249023 | ||
| Pubmed | Phage display of a human antibody against Clostridium tetani toxin. | 2.43e-05 | 2 | 172 | 2 | 7926831 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 1651314 | ||
| Pubmed | DNA dependent recruitment of DDX17 and other interacting proteins by the human androgen receptor. | 2.43e-05 | 2 | 172 | 2 | 19059367 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 28739342 | ||
| Pubmed | FHOD1 interaction with nesprin-2G mediates TAN line formation and nuclear movement. | 2.43e-05 | 2 | 172 | 2 | 24880667 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18648652 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26327810 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16547269 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22768332 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16860317 | ||
| Pubmed | SLC35E2 promoter mutation as a prognostic marker of esophageal squamous cell carcinoma. | 2.43e-05 | 2 | 172 | 2 | 35247439 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21460185 | ||
| Pubmed | Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men. | 2.43e-05 | 2 | 172 | 2 | 22882535 | |
| Pubmed | Functional and non-functional joining in immunoglobulin light chain genes of a mouse myeloma. | 2.43e-05 | 2 | 172 | 2 | 6776411 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 8325334 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 2.43e-05 | 2 | 172 | 2 | 17267447 | |
| Pubmed | Fetal Leydig Cells Persist as an Androgen-Independent Subpopulation in the Postnatal Testis. | 2.43e-05 | 2 | 172 | 2 | 26402718 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11181993 | ||
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 2.43e-05 | 2 | 172 | 2 | 24718612 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 24586179 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11070051 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18162522 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17761684 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11312274 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 31578382 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23212659 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 8372513 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22309849 | ||
| Pubmed | 3.28e-05 | 13 | 172 | 3 | 21177258 | ||
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 4.13e-05 | 77 | 172 | 5 | 15608191 | |
| Pubmed | HSCB CAD UNC5B SYNE1 SF3A1 UBL4A SLC30A1 DCTN1 CEMIP2 PREB WDR3 THADA IGF2R SUGT1 MOGS SACS SYNE2 CLPTM1 IFT122 NEURL4 | 5.04e-05 | 1487 | 172 | 20 | 33957083 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 8188237 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 28381560 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 29727258 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 6091049 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 29249800 | ||
| Pubmed | Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. | 7.27e-05 | 3 | 172 | 2 | 11847099 | |
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 7.27e-05 | 3 | 172 | 2 | 16079285 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 32416252 | ||
| Pubmed | Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. | 7.27e-05 | 3 | 172 | 2 | 15889138 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 17082327 | ||
| Pubmed | Netrin-1 mediates neuronal survival through PIKE-L interaction with the dependence receptor UNC5B. | 7.27e-05 | 3 | 172 | 2 | 18469807 | |
| Pubmed | Coordinated internodal and paranodal adhesion controls accurate myelination by oligodendrocytes. | 7.27e-05 | 3 | 172 | 2 | 31451613 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 20147635 | ||
| Pubmed | CD200R1 supports HSV-1 viral replication and licenses pro-inflammatory signaling functions of TLR2. | 7.27e-05 | 3 | 172 | 2 | 23082204 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 8747461 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 10878022 | ||
| Pubmed | Primate-specific spliced PMCHL RNAs are non-protein coding in human and macaque tissues. | 7.27e-05 | 3 | 172 | 2 | 19068116 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 12408964 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 24129569 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 34232601 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 17462627 | ||
| Pubmed | Lamins and nesprin-1 mediate inside-out mechanical coupling in muscle cell precursors through FHOD1. | 7.27e-05 | 3 | 172 | 2 | 28455503 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 27133561 | ||
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 7.27e-05 | 3 | 172 | 2 | 25516977 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 19126541 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 16615898 | ||
| Pubmed | 7.68e-05 | 17 | 172 | 3 | 8223863 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 9.46e-05 | 212 | 172 | 7 | 33462405 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCAPD3 EYA4 SF3A1 TRPS1 LARS1 TEX10 DCTN1 TBC1D4 KANSL1 A2ML1 LRP1 UTP20 CCAR2 NOTCH1 | 1.00e-04 | 857 | 172 | 14 | 25609649 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.03e-04 | 289 | 172 | 8 | 23752268 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | EYA4 DDX17 MYO5B SF3A1 LARS1 DCTN1 HDAC7 TRAP1 THADA TBC1D4 SBNO1 CLPTM1 CCAR2 UBAC2 IFT122 LUM TBR1 NEURL4 | 1.04e-04 | 1321 | 172 | 18 | 27173435 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NCAPD3 DDX17 POLR1A LARS1 SRBD1 TEX10 WDR3 PBRM1 ARID2 UTP20 CCAR2 NEURL4 DDX28 | 1.12e-04 | 759 | 172 | 13 | 35915203 |
| Pubmed | Affinity purification strategies for proteomic analysis of transcription factor complexes. | 1.25e-04 | 97 | 172 | 5 | 23937658 | |
| Pubmed | 1.27e-04 | 20 | 172 | 3 | 20716560 | ||
| Pubmed | 1.45e-04 | 4 | 172 | 2 | 7524394 | ||
| Pubmed | CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS. | 1.45e-04 | 4 | 172 | 2 | 27698445 | |
| Pubmed | 1.45e-04 | 4 | 172 | 2 | 6264318 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | IGKV1-39 KDM3A IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 POLR1A IGKV1D-39 IGKV1D-13 IGKV1D-12 | 9.31e-09 | 213 | 172 | 10 | chr2p11 |
| Cytoband | 2p12 | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 1.59e-08 | 117 | 172 | 8 | 2p12 |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 5.56e-08 | 83 | 115 | 8 | 351 |
| GeneFamily | Solute carriers | SLC43A2 SLC29A3 SLC22A23 SLC22A15 SLC35E2B SLC15A3 SLC30A1 SLC22A7 SLC12A1 SLC18A2 SLC35E2A | 4.39e-05 | 395 | 115 | 11 | 752 |
| GeneFamily | Glycoprotein hormone receptors | 1.20e-04 | 3 | 115 | 2 | 199 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.39e-04 | 4 | 115 | 2 | 1252 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 2.54e-03 | 12 | 115 | 2 | 573 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 SUGT1 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 2.47e-06 | 132 | 170 | 8 | MM996 |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP | 6.43e-06 | 199 | 170 | 9 | M8748 | |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN | 2.71e-05 | 183 | 170 | 8 | M7627 | |
| Coexpression | GSE3982_MAST_CELL_VS_NKCELL_DN | 4.92e-05 | 199 | 170 | 8 | M5452 | |
| Coexpression | GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN | 5.09e-05 | 200 | 170 | 8 | M7907 | |
| Coexpression | GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN | 5.09e-05 | 200 | 170 | 8 | M5724 | |
| Coexpression | GSE7852_LN_VS_FAT_TREG_UP | 5.09e-05 | 200 | 170 | 8 | M5739 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 TSHR LIME1 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 5.07e-09 | 196 | 172 | 10 | c38e7f533c619afe008de0e99042f7180c2da918 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 TSHR LIME1 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 6.56e-08 | 193 | 172 | 9 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 LIME1 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 6.86e-08 | 194 | 172 | 9 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 TSHR IGKV1D-39 IGKV1D-13 IGKV1D-12 | 7.48e-08 | 196 | 172 | 9 | fec21383435779bf4c632decd3d29c6ca7baebfb |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 TSHR LIME1 IGKV1D-39 IGKV1D-13 | 7.48e-08 | 196 | 172 | 9 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | IGKV1-39 IGKV1-12 IGKV1-8 IGKV1-6 TSHR IGKV1D-39 IGKV1D-13 IGKV1D-12 | 4.36e-07 | 176 | 172 | 8 | 50e207403d48ce1b55a78897adb5519a2430a626 |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 4.36e-07 | 176 | 172 | 8 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.17e-07 | 180 | 172 | 8 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-12 IGKV1-8 TSHR LIME1 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 6.37e-07 | 185 | 172 | 8 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-12 IGKV1-8 TSHR LIME1 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 6.37e-07 | 185 | 172 | 8 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 8.76e-07 | 193 | 172 | 8 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-12 IGKV1-8 IGKV1-6 TSHR LIME1 IGKV1D-39 IGKV1D-13 | 9.47e-07 | 195 | 172 | 8 | 13f4ee21568fd747608412d33559d10561dbb3c8 |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | IGKV1-39 IGKV1-12 IGKV1-8 IGKV1-6 TSHR LIME1 IGKV1D-39 IGKV1D-13 | 9.47e-07 | 195 | 172 | 8 | d0305c6a68c9e361507b04db94f86873085d49b3 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 9.47e-07 | 195 | 172 | 8 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 9.84e-07 | 196 | 172 | 8 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.02e-06 | 197 | 172 | 8 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 1.02e-06 | 197 | 172 | 8 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.14e-06 | 200 | 172 | 8 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 3.27e-06 | 162 | 172 | 7 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 3.27e-06 | 162 | 172 | 7 | f945688815229c8386cbcbf46deee7df316fa8d3 |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.67e-06 | 171 | 172 | 7 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.85e-06 | 172 | 172 | 7 | d1ab8f493b70ec995281f9fb0991f1d3aa7b928f | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 175 | 172 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass | 6.08e-06 | 178 | 172 | 7 | f75591988bbbeba073b66329a3437cb9b02f7648 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGKV1-39 IGKV1-12 IGKV1-8 LIME1 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 7.29e-06 | 183 | 172 | 7 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | IGKV1-39 IGKV1-13 IGKV1-12 TSHR IGKV1D-39 IGKV1D-13 IGKV1D-12 | 7.55e-06 | 184 | 172 | 7 | 6f70d8f8ab8362d51f8a58735d42223e06566397 |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-06 | 186 | 172 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.31e-06 | 190 | 172 | 7 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.31e-06 | 190 | 172 | 7 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | Severe-Lymphoid-NK-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 9.31e-06 | 190 | 172 | 7 | e67803bf55a3f8e47a69ff1829c9100f870d7527 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 9.31e-06 | 190 | 172 | 7 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 9.31e-06 | 190 | 172 | 7 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.63e-06 | 191 | 172 | 7 | 81f77bf497b8e0ae0affe7d5f4f00446547229f6 | |
| ToppCell | mild-Myeloid-CD16_Monocytes|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.10e-05 | 195 | 172 | 7 | e963d33b50d43e38cada738e41343b64e3d08b79 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 1.10e-05 | 195 | 172 | 7 | df009b18898c10686f75cf72b4ec0eff18f5bb50 |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 1.14e-05 | 196 | 172 | 7 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-05 | 196 | 172 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 197 | 172 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19_Severe-Myeloid-Non-classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class | 1.18e-05 | 197 | 172 | 7 | c5837b9a5a39a0f607a4e217ade9fc87d82a5406 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Plasma_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.18e-05 | 197 | 172 | 7 | 275f38ed7e477000e864cecf9b7d49ae134c3b6a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 197 | 172 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-05 | 198 | 172 | 7 | d36a3cda7e5f385d2391e9b0dfb027d3c4549320 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 198 | 172 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-05 | 198 | 172 | 7 | 5436c3ed16e10e00c686f1ab0b0a68728a1a9985 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-05 | 198 | 172 | 7 | 4f67067d8142ca11b2d80195dac8d62a8d24d52c | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-05 | 198 | 172 | 7 | 9b8679b3dd8f4220d71f607b7080cb88d6e71129 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-05 | 198 | 172 | 7 | 8b6b602ebe59b6dca6a22f17385d3160ff3ac67e | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-05 | 198 | 172 | 7 | b9030390316baf456135f85f831394e1e11ecf3e | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 1.22e-05 | 198 | 172 | 7 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-05 | 199 | 172 | 7 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.26e-05 | 199 | 172 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.26e-05 | 199 | 172 | 7 | 727122b6f4ca265d2826c9271b10a4215a9d45a3 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class | 1.30e-05 | 200 | 172 | 7 | 58fbb7fc7159cbc417e6b457d60b7beba9b90da6 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-05 | 200 | 172 | 7 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | COVID|World / Condition, Cell_class and T cell subcluster | 1.30e-05 | 200 | 172 | 7 | 04a932fe2431e7886120c219ce666f90d3030a1c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.30e-05 | 200 | 172 | 7 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.06e-05 | 144 | 172 | 6 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-05 | 149 | 172 | 6 | c957ac23ad6343eacce7e6be4a6d3ac043af4f86 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-05 | 149 | 172 | 6 | 4de52569611e63a780cde9bd111d6d9c11a05a11 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 3.60e-05 | 159 | 172 | 6 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.86e-05 | 161 | 172 | 6 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 166 | 172 | 6 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 166 | 172 | 6 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.89e-05 | 168 | 172 | 6 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 4.89e-05 | 168 | 172 | 6 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.06e-05 | 169 | 172 | 6 | f68195510b91e287fe1507455ca067ece77a3897 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.06e-05 | 169 | 172 | 6 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.23e-05 | 170 | 172 | 6 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-05 | 170 | 172 | 6 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.23e-05 | 170 | 172 | 6 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.23e-05 | 170 | 172 | 6 | 12aa9bdb18f3bf6da2a25984d08fe9497e5570ed | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.23e-05 | 170 | 172 | 6 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.23e-05 | 170 | 172 | 6 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.76e-05 | 173 | 172 | 6 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 173 | 172 | 6 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.76e-05 | 173 | 172 | 6 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 173 | 172 | 6 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.76e-05 | 173 | 172 | 6 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.76e-05 | 173 | 172 | 6 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-05 | 174 | 172 | 6 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-05 | 174 | 172 | 6 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 6.14e-05 | 175 | 172 | 6 | d73ee324479172501481b54967a0f3bd870fcf3a | |
| ToppCell | ASK452-Epithelial-Secretory|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.33e-05 | 176 | 172 | 6 | dd334c8a8a31dc26b2d558df0ef6bed6dc1a6610 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-05 | 176 | 172 | 6 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.54e-05 | 177 | 172 | 6 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | 6.54e-05 | 177 | 172 | 6 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 | |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | 6.54e-05 | 177 | 172 | 6 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.54e-05 | 177 | 172 | 6 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 178 | 172 | 6 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.95e-05 | 179 | 172 | 6 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 7.17e-05 | 180 | 172 | 6 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.17e-05 | 180 | 172 | 6 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 7.39e-05 | 181 | 172 | 6 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 181 | 172 | 6 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.39e-05 | 181 | 172 | 6 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.39e-05 | 181 | 172 | 6 | e47664a264a2c37390d1668ce04eef2e0172f4cb | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Otof_(eccentric_SPN,_iSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.45e-05 | 58 | 172 | 4 | af702c318fc970707660e5d0cfb7b08df3a6e809 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Otof_(eccentric_SPN,_iSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.45e-05 | 58 | 172 | 4 | 538f572db2f34b71058cf09d2db374a906f53580 | |
| Disease | Dysosteosclerosis | 2.71e-05 | 2 | 154 | 2 | C0432262 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.61e-04 | 4 | 154 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.68e-04 | 5 | 154 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.68e-04 | 5 | 154 | 2 | C0410190 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 3.51e-04 | 115 | 154 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.00e-04 | 6 | 154 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.00e-04 | 6 | 154 | 2 | C0410189 | |
| Disease | Bartter syndrome | 4.00e-04 | 6 | 154 | 2 | cv:C0004775 | |
| Disease | monocyte percentage of leukocytes | PIK3AP1 POLR1A TRPS1 MED13L S1PR1 TRAP1 THADA KANSL1 CSF3R CIITA SPSB4 NEURL4 | 4.76e-04 | 731 | 154 | 12 | EFO_0007989 |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.59e-04 | 7 | 154 | 2 | C0751337 | |
| Disease | asthma | EYA4 RANBP6 TMTC2 ATP10B HDAC7 CRB1 TRAP1 IPCEF1 LRP1 STARD3 UBAC2 CARD11 | 6.04e-04 | 751 | 154 | 12 | MONDO_0004979 |
| Disease | Hereditary spherocytosis | 7.42e-04 | 8 | 154 | 2 | C0037889 | |
| Disease | coronary aneurysm | 8.07e-04 | 35 | 154 | 3 | EFO_1000881 | |
| Disease | hemorrhoid | 1.07e-03 | 147 | 154 | 5 | EFO_0009552 | |
| Disease | Colorectal Carcinoma | EYA4 CAD ZNF560 SYNE1 SF3A1 SLC22A15 PREX2 SACS TLR2 LRP1 ABCG2 | 1.19e-03 | 702 | 154 | 11 | C0009402 |
| Disease | Inhalant adrenergic use measurement | 1.63e-03 | 96 | 154 | 4 | EFO_0009941 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.73e-03 | 12 | 154 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | high density lipoprotein particle size measurement | 2.03e-03 | 170 | 154 | 5 | EFO_0008592 | |
| Disease | lymphocyte percentage of leukocytes | PIK3AP1 TTC28 HDAC7 S1PR1 THADA SLC12A1 KANSL1 CSF3R SBNO1 CARD11 | 2.67e-03 | 665 | 154 | 10 | EFO_0007993 |
| Disease | nervous system disorder | 2.70e-03 | 53 | 154 | 3 | C0027765 | |
| Disease | Anilide use measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0009938 | |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 2.72e-03 | 15 | 154 | 2 | EFO_0004611, EFO_0005658 | |
| Disease | infant head circumference | 2.72e-03 | 15 | 154 | 2 | EFO_0004577 | |
| Disease | response to TNF antagonist | 2.85e-03 | 54 | 154 | 3 | EFO_0004653 | |
| Disease | cathepsin L1 measurement | 3.10e-03 | 16 | 154 | 2 | EFO_0010619 | |
| Disease | Antihistamine use measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0009943 | |
| Disease | sphingomyelin 14:0 measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0010390 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.66e-03 | 195 | 154 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 3.78e-03 | 121 | 154 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | sinusitis (is_marker_for) | 3.92e-03 | 18 | 154 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | lymphocyte count | PIK3AP1 SLC29A3 PCDHGC4 TTC28 NHLRC2 MED13L HDAC7 S1PR1 PREX2 FOCAD THADA PBRM1 SLC12A1 SBNO1 CARD11 NEURL4 | 4.23e-03 | 1464 | 154 | 16 | EFO_0004587 |
| Disease | Lipoidosis | 4.37e-03 | 19 | 154 | 2 | C0023794 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 4.37e-03 | 19 | 154 | 2 | EFO_0007709 | |
| Disease | osteoporosis (implicated_via_orthology) | 4.37e-03 | 19 | 154 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | seborrheic dermatitis | 4.83e-03 | 20 | 154 | 2 | EFO_1000764 | |
| Disease | uric acid measurement | 4.88e-03 | 610 | 154 | 9 | EFO_0004761 | |
| Disease | apolipoprotein A 1 measurement | PPP1R21 MYO5B TRPS1 TSHR NHLRC2 LHCGR SBNO1 CLPTM1 LRP1 STARD3 TAGLN | 5.06e-03 | 848 | 154 | 11 | EFO_0004614 |
| Disease | hair colour measurement | 5.14e-03 | 615 | 154 | 9 | EFO_0007822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSSKVLLLSSPGLEE | 306 | Q8N163 | |
| TASPLYLLLKAPSSL | 471 | P16452 | |
| ILGLAYATLAKPSSS | 196 | Q9Y5Z0 | |
| YLPGSKLLDRFLSLS | 131 | Q86U37 | |
| LLVDSQLDSPKALYL | 1171 | P78357 | |
| SLLLLILPGYSIAAK | 6 | Q6UXZ3 | |
| SPLLKALSGNYSAPL | 2421 | Q7Z408 | |
| SELPAGALYRKTSQL | 1141 | Q14203 | |
| LKYTGNASALFILPD | 266 | P01011 | |
| AKLPSTLTGLYVGLL | 631 | P33076 | |
| GAYKLAEALPSLAAS | 1031 | P33076 | |
| PLSALYGTLSLLQQL | 491 | Q9BYG8 | |
| LTAYALLAQLTKPSL | 1196 | A8K2U0 | |
| VSSYFLGKLLSDLLP | 466 | Q9UNQ0 | |
| AEQTPLTALYLGSLI | 206 | P47895 | |
| NDYNKLVLSLLSGLP | 156 | Q68CP9 | |
| AKYEQLLFLAPLSTS | 1036 | Q99490 | |
| YGLKNLTALLLTCPG | 346 | Q6ZUJ8 | |
| TSYIPDFLTLLNKGS | 431 | Q6P1M9 | |
| AETLLALPELYKSGQ | 1171 | O94823 | |
| LKASLAADIPRLGYS | 21 | Q8N0X4 | |
| SYKAFAAIPTNTLLL | 211 | Q5VWP3 | |
| YSLAPVAVELKSLLG | 76 | P07205 | |
| LSYQLLKATEPGLFS | 601 | Q9Y5E4 | |
| TPLDEKSLALLLNYL | 316 | Q9UBU8 | |
| LATGLSALYSSLPRK | 261 | Q8N612 | |
| GSSPAYLKEILEQLL | 176 | Q86U86 | |
| KNGEILLSPALSYTT | 881 | Q86U86 | |
| PKLLIYAASSLQSGV | 66 | P04432 | |
| LASLGSLNIPYKIEA | 1706 | P46531 | |
| ALPAAELGLYSLVLS | 6 | Q9HCP6 | |
| LVYDTSDGTLLQPLK | 36 | Q9HBG6 | |
| STKLQALPSYGLESI | 231 | P22888 | |
| APYLATLQLDSSLLI | 1511 | Q71F56 | |
| TLLLSNVSPELGGKY | 101 | P20916 | |
| PKLLIYAASSLQSGV | 66 | P01611 | |
| LITLSATFYGLKPDL | 246 | Q6PRD1 | |
| LAKLSYVLGQPGLSL | 331 | Q86U10 | |
| GLLSSLESLDLSYNP | 91 | A6NIV6 | |
| LLIAYGASKPNALSV | 131 | Q8N370 | |
| TLLDLELYNPKGIAL | 316 | Q07954 | |
| LGYKLLPAFNTTSGL | 186 | Q9BZQ6 | |
| PKLLIYDASSLESGV | 66 | A0A0B4J2D9 | |
| LRYLDLSKNPGLLAT | 336 | Q8ND23 | |
| SGSPALSLLIILYVK | 231 | Q6Q8B3 | |
| GTLQVYSDSLLTLPA | 1231 | Q9UIW2 | |
| TLPLIAVYLLSALGN | 36 | Q8NGJ8 | |
| SGKTLSYLLPLLQRL | 176 | Q9NUL7 | |
| DLGKLQPLVASYLCS | 71 | Q7Z3B3 | |
| SPSGLYQLDLLSTEK | 141 | Q8TB73 | |
| APLLISLSTLIYNGA | 766 | P55268 | |
| DLDLALGYCTLLPQK | 1341 | P50748 | |
| SYNKLETLPSQLGLC | 661 | Q6NSJ5 | |
| LPSTLSLYKSGALDE | 341 | P10275 | |
| GPQKTGTTALYLFLL | 601 | Q9H3R1 | |
| DPDSGLNALISYSLL | 481 | Q9Y5F7 | |
| EKLQTYIALLALPST | 396 | Q6ZMI0 | |
| LSGLLPAQTSLEYAL | 11 | Q8NBF2 | |
| TLLNPKTLPSGLDDY | 571 | Q13724 | |
| LSYQLLKATEPGLFG | 601 | Q9Y5E5 | |
| LLLPLLNLYTGSVAS | 6 | A0A075B6J6 | |
| QLIPALAKVLLYSLG | 551 | O95677 | |
| LYKSLEQASLSPLGD | 316 | Q8WWN9 | |
| YKPLLDKAGLGSITS | 116 | Q9Y4C1 | |
| TRGSLSPTKYNLLEL | 21 | A2RUU4 | |
| KEVLLSLTYAANAGP | 61 | Q5T1B0 | |
| ERLPKLSLYSGESLL | 591 | Q8ND61 | |
| ALAIILGISSKYAPD | 96 | Q9UHN6 | |
| LLAGLTPSPKSYENL | 776 | Q99062 | |
| SGLPVSLLTLYLDNN | 201 | P51884 | |
| NSLTSLPLEILKYIA | 571 | Q9UH90 | |
| GLSLNLVIKPYLALE | 16 | Q16048 | |
| GLSLNLVIKPYLALE | 16 | Q9BQD1 | |
| IYSTLLGLPADIQAA | 66 | P57739 | |
| SAALLDKLYALGLVP | 76 | Q9NV31 | |
| PKLLIYAASSLQSGV | 66 | A0A0C4DH72 | |
| GKAPKLLIYAASTLQ | 61 | A0A0C4DH67 | |
| PKLLIYAASSLQSGV | 66 | A0A0C4DH73 | |
| PKLLIYDASSLESGV | 66 | P0DP09 | |
| PKLLIYAASSLQSGV | 66 | P01597 | |
| QTGSGKTLAYLLPAI | 216 | Q92841 | |
| VLLYGTNPLSRLKLD | 586 | Q8WUI4 | |
| NAILEKLYSSSGPEL | 121 | Q9Y613 | |
| LQPSGLLLALENSTY | 746 | P82279 | |
| LSLPKLTYGGIALLA | 491 | Q9Y694 | |
| IYANLALSGLIEIPS | 336 | Q8IZD6 | |
| LSLLLYLAASGLLPA | 106 | Q8IY34 | |
| NLLLSGATTYKLTPA | 101 | P21453 | |
| ALYLPSQDGRLVKSS | 3906 | Q9NZJ4 | |
| KLYSLLGIDLTAPSN | 676 | A3KN83 | |
| ESELGKNLSLIPYSL | 951 | Q9BXL7 | |
| VLLSPSLQYAGAETL | 1476 | Q96JN8 | |
| DLSVPGSCYLKLLSL | 751 | Q5VW36 | |
| LSASINPILYNLISK | 346 | O43193 | |
| PKSLERLLLGYNEIS | 161 | Q99983 | |
| LPDLIYTLLLQLGSS | 1246 | A6NES4 | |
| STLVNDAYKTLLAPL | 121 | Q8IWL3 | |
| LNPLIKLSGAYLVDD | 186 | P11717 | |
| LQEDAGLLSLLYLPT | 616 | Q9BVN2 | |
| SDVYPALLSSLLGLS | 411 | Q9BZD2 | |
| LGSESQYSPTPLLKL | 1191 | O75691 | |
| SILLLSYGLISENLP | 2021 | O75691 | |
| SYGLISENLPLLTEK | 2026 | O75691 | |
| ILAGIYLSLSLKNPL | 81 | Q6YHU6 | |
| STLPGQSLIDKLYNI | 376 | O95602 | |
| ATLLSYAAAGVKALP | 511 | Q16650 | |
| ELGELLLSLNYLPSA | 321 | Q9BSW7 | |
| LGLYTILPSELSLQL | 5386 | Q8NF91 | |
| LLIQAYSAKILPSLL | 4791 | Q8WXH0 | |
| GEVLSILLYLAPNSS | 306 | Q6IEE7 | |
| LDPLASLKSLTYLSI | 106 | P09661 | |
| LKLQLASIVPLYSSL | 71 | Q9H0A3 | |
| EILGASLSAPLTSYK | 356 | Q9P2J5 | |
| AAPSLLLLDYDGSVL | 71 | A1A5C7 | |
| LKSPLETLALTYGSL | 291 | Q5SWL8 | |
| LNLPNLAAAYSSILS | 66 | P30793 | |
| LLVDLINSLPLYSLG | 486 | Q9BRB3 | |
| PGAELSLCYQKALLS | 586 | Q5UE93 | |
| NTLGYSDLGPIKSLR | 1276 | Q15858 | |
| FLNKYILSLLGGEPS | 91 | P0CK97 | |
| SLPVARKGSISDLLY | 1056 | Q13621 | |
| ISQLGEKYSLPLRTS | 516 | O15457 | |
| ILSKLVNSLYPDGSK | 61 | Q01995 | |
| ALALLLTYSGTEKFP | 646 | Q9NQW1 | |
| YAPGLDIESSLKQLA | 456 | Q15459 | |
| PYLEDTLQLSLKLCG | 261 | O60518 | |
| LLNKGLTSYIGTFDP | 101 | Q9UIY3 | |
| LSLLSYIRPDVKGLS | 346 | Q8N5C6 | |
| LSELLSKGAFGYLLP | 141 | Q14849 | |
| ALLLASYFLLLTSPE | 221 | Q13286 | |
| KVALLETNPYLLALT | 346 | O96005 | |
| LLSKIAGSSPRLDYS | 721 | P42695 | |
| ATSKPVYSALATLLL | 321 | P51800 | |
| LYALQVDPSTGLLIA | 16 | Q9HCU5 | |
| LTPYDSLLGKNRKAL | 1666 | O15417 | |
| LGLTYLSLLLIPAAA | 16 | A6NLX4 | |
| TPYSSLKKLLSLLNG | 6 | Q9UKR8 | |
| IPLPSLSKYEAQGSL | 996 | Q9UHF7 | |
| LLLSTKYAASLPALL | 566 | Q9P2K2 | |
| PNYSGTIALALLVSL | 196 | Q13454 | |
| LSALVLLTQPLGYLE | 6 | P35247 | |
| NALSTVLPGLAYLAT | 361 | Q9NXZ1 | |
| DISSLPLPQSLKNYL | 256 | Q96A44 | |
| LKTLSLSYNALGAPA | 1191 | Q96HA7 | |
| KLAIGSRPTLASAYL | 551 | Q8N394 | |
| QGLQLLLKYLSGSTL | 61 | A0A0B4J262 | |
| ALGTSKLNYLDPRIS | 551 | Q969P6 | |
| SALLGLKDLLSQYPF | 76 | Q9NXF1 | |
| YPALITGRSSILLKN | 171 | Q9NXF1 | |
| ESKQNPGSIYCLLLL | 81 | B1AK76 | |
| QIDDLLSSITYSPKL | 1046 | Q70Z35 | |
| FLNKYILSLLGGEPS | 91 | P0CK96 | |
| PVLLIALYKAGELTS | 61 | P0DPF4 | |
| LSALVKLPSGEDYNL | 206 | Q9Y2Z0 | |
| YLLINKAESTLPLSE | 581 | Q8IZJ1 | |
| GLYASLTTLPSEALQ | 836 | Q9ULM0 | |
| PGQLSLFNLLKAYSL | 986 | O60343 | |
| LLTIGSYKNKSELLP | 1316 | P27708 | |
| LSGLYEFPLNKVDSL | 251 | Q9UJA5 | |
| LIPFALLKGSSSNEY | 1431 | Q96AY4 | |
| KLLRYESSALPSGQL | 466 | Q12931 | |
| LSDYSIGPNSKLNLV | 56 | P11441 | |
| LGNSPYDIALVKLSA | 131 | Q9Y6M0 | |
| GSSGLYKAPLSKSLL | 6 | Q8NBM4 | |
| SYSPNQKLLAVSLLD | 556 | Q9UNX4 | |
| TTYPLLKESALILLQ | 331 | Q9Y6M5 | |
| SAKLYLTPSNIVLLT | 556 | Q8TB96 | |
| LDGESIYSLTSKPIL | 146 | Q6P3X3 | |
| TTLLKDPYILIAAGS | 286 | Q05940 | |
| LLGNPYKTLGETSLF | 131 | O60603 | |
| LSSVGYQLFKPSLIS | 146 | Q96MR9 | |
| LGSLLKLSLYFSAGL | 216 | Q9NX78 | |
| SKPLLGLGSSVIYFL | 191 | Q9H6D3 | |
| LLALLPLVGISSYAK | 551 | P16473 | |
| ILALAGDLAYQTLPL | 226 | Q9H400 | |
| SPDSYSLLLNQLKLA | 1236 | Q9ULV0 | |
| LTGDQSRSLPYKLIS | 91 | Q9NZM1 |